NIPH Clinical Trials Search

Basic Information

Recruitment status
Health condition(s) or Problem(s) studied	Secondary Hyperparathyroidism
Date of first enrollment	19/05/2008
Target sample size
Countries of recruitment
Study type	Interventional
Intervention(s)	investigational material(s) Generic name etc : ABT-358 INN of investigational material : Paricalcitol Therapeutic category code : 311 Vitamin A, D and preparations Dosage and Administration for Investigational material : IV (administered through intravenous-catheter of the dialysis)

Outcome(s)

Primary Outcome	The proportion of subjects with >=50% decrease from baseline in iPTH at the final visit
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum	>= 20age old
Age maximum	Not applicable
Gender	Both
Include criteria	Aged 20 or over Chronic kidney disease subjects receiving hemodialysis with secondary hyperparathyroidism
Exclude criteria